14.07.2013 Views

Clinical Trials and Preclinical Infrastructure Asset Map - Genome BC

Clinical Trials and Preclinical Infrastructure Asset Map - Genome BC

Clinical Trials and Preclinical Infrastructure Asset Map - Genome BC

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

42<br />

Network B.C. Investigator’s Role<br />

Integrative Analysis of Longitudinal<br />

Studies of Aging (IALSA) Research Network<br />

(http://lifelab.tss.oregonstate.edu/)<br />

International Photodynamic Association<br />

(IPA) (http://sites.pcmd.ac.uk/ipa/<br />

index.php)<br />

National Core for Neuroethics (www.<br />

neuroethics.ubc.ca)<br />

Co-directed by Scott Hofer, Victoria B.C.<br />

VCHRI’s Stephen Lam is a past President.<br />

Based at U<strong>BC</strong> in Vancouver B.C.<br />

BRITISH COLUMBIA<br />

TABLE 13. Examples of National <strong>and</strong> International Networks In Which B.C.’s <strong>Clinical</strong> Investigators<br />

Play a Pivotal Role (cont’d)<br />

Independent Corporations Offering <strong>Clinical</strong> <strong>Trials</strong> Services<br />

B.C. is home to at least 25 independent organizations that offer clinical trials services, as listed in Table<br />

14 <strong>and</strong> Appendix 11. These are generally for-profit (the exception is the Victoria Heart Institute Foundation).<br />

The focus of these companies is shown in Figure 15, with 64% involved in setting up <strong>and</strong> managing<br />

clinical trials. Of the eight investigator-operated clinical trials companies, five are disease-specific<br />

(one each dealing with cancer, urology, endocrinology, gastrointestinal, <strong>and</strong> cardiology). A number of<br />

the analytical services companies also offer preclinical services (see below).<br />

FIGURE 15. Focus on Independent <strong>Clinical</strong> <strong>Trials</strong> Organizations<br />

N= 5 (20%)<br />

N= 4 (16%)<br />

N= 8 (32%)<br />

N= 8 (32%)<br />

Other = two health outcomes consultancies; one REB; one medical software company<br />

PI Managed <strong>Clinical</strong> <strong>Trials</strong> Company<br />

Other <strong>Clinical</strong> <strong>Trials</strong> Management Companies<br />

Analytical Services<br />

Other

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!